About Publications

Publications from the National Academies of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes Health and Medicine Division (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.


  • The Drug Development Paradigm in Oncology: Proceedings ... Released: July 24, 2017
    Advances in cancer research have led to an improved understanding of the molecular mechanisms underpinning the development of cancer and how the immune system responds to cancer. This influx of research has led to an increasing number and variety of cancer therapies in the drug development pipeline. Compared with standard chemotherapies, these new cancer therapies may demonstrate evidence of benefit at an earlier stage of development.
  • Cancer Care in Low-Resource Areas: Cancer Treatment ... Released: May 23, 2017
    Though cancer was once considered to be a problem primarily in wealthy nations, low- and middle-income countries now bear a majority share of the global cancer burden. Disparities in cancer outcomes also exist in high-income countries—communities within wealthier nations can experience worse cancer outcomes, especially if they have challenges in accessing cancer prevention and cancer care services.
  • Developing Affordable and Accessible Community-Based ... Released: May 17, 2017
    Accessible and affordable housing can enable community living, maximize independence, and promote health for vulnerable populations. However, the United States faces a shortage of affordable and accessible housing for vulnerable low-income older adults and individuals living with disabilities. This shortage is expected to grow over the coming years given the population shifts leading to greater numbers of older adults and of individuals living with disabilities.
  • Future Financial Economics of Health Professional Education ... Released: April 05, 2017
    The Government Accountability Office (GAO), World Health Organization (WHO), and the World Bank all agree that “an adequate, well-trained, and diverse health [care] workforce is essential for providing access to quality health [care] services.” However, according to the World Bank, efforts to scale up the supply of health workers are falling short. The resulting health workforce shortage affects people’s access to quality health care around the globe, and can result in untreated sickness, disability, and adverse economic consequences.
  • Integration of FDA and NIOSH Processes Used to Evaluate ... Released: February 01, 2017
    The Food and Drug Administration (FDA) and the National Institute for Occupational Safety and Health (NIOSH) have responsibilities for evaluating and regulating respiratory protective devices (RPDs) for health care workers. To provide input to NIOSH and FDA and to discuss potential next steps to integrate the two agencies’ processes to certify and approve N95 respirators for use in health care settings, a workshop was held by the National Academies of Sciences, Engineering, and Medicine (the National Academies).
  • Enhancing BioWatch Capabilities Through Technology and ... Released: December 05, 2016
    In response to the 2015 Government Accountability Office (GAO) report Biosurveillance: DHS Should Not Pursue BioWatch Upgrades or Enhancements Until System Capabilities Are Established, the Department of Homeland Security (DHS) requested that the National Academies of Sciences, Engineering, and Medicine conduct a workshop to further explore the findings of the 2015 GAO report and discuss the impact these findings may have with regard to the future development of the technical capabilities of the BioWatch program.
  • Strengthening the workforce to Support Community Living and ... Released: November 22, 2016
    As the demographics of the United States shift toward a population that is made up of an increasing percentage of older adults and people with disabilities, the workforce that supports and enables these individuals is also shifting to meet the demands of this population. To better understand how the nation’s workforce can be strengthened to meet these demands, the Health and Medicine Division and the Division of Behavioral and Social Sciences and Education of the National Academies of Sciences, Engineering, and Medicine, convened a public workshop with support from multiple sponsors.
  • Implementation of Lung Cancer Screening: Proceedings of a ... Released: November 17, 2016
    Lung cancer is the leading cause of cancer-related death in the United States; each year, more people die from lung cancer than from colon, breast, and prostate cancers combined. There has been a push to develop and implement screening strategies for the early detection of lung cancer. The National Lung Screening Trial evaluated the effectiveness of annual screening with low-dose computed tomography to reduce lung cancer mortality among individuals at high risk.
  • Exploring the Role of Accreditation in Enhancing Quality and ... Released: October 05, 2016
    The purpose of accreditation is to build a competent health workforce by ensuring the quality of training taking place within those institutions that have met certain criteria. Given the rapid changes in society, health, and health care, members of the Global Forum on Innovation in Health Professional Education elected to take on the topic of accreditation and to explore the effect of societal shifts on new and evolving health professional learning opportunities to best ensure quality education is offered by institutions regardless of the program or delivery platform.
  • Policy Issues in the Clinical Development and Use of ... Released: July 19, 2016
    To examine challenges in the development and implementation of immunotherapies into clinical practice and explore strategies to overcome them, the National Cancer Policy Forum of the National Academies of Sciences, Engineering, and Medicine held the workshop “Policy Issues in the Clinical Development and Use of Immunotherapy for Cancer” on February 29 and March 1, 2016, in Washington, DC.